Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Heitmeier

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|April 8, 2015
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo StudiesElisabeth Perzborn, Stefan Heitmeier, Volker Laux
Journal of Thrombosis and Thrombolysis|February 6, 2023
The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidenceSonja Schiffer, Stephan Schwers, Stefan Heitmeier
Thrombosis Research|February 18, 2014
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitroElisabeth Perzborn, Stefan Heitmeier, Volker Laux, et al.
Thrombosis Research|June 7, 2020
The dual FXa/thrombin inhibitor SATI prevents fibrin and platelet deposition in hypercoagulant ratsMercedes López, Stefan Heitmeier, Volker Laux, et al.
Thrombosis and Haemostasis|June 29, 2020
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the EvidenceJeffrey Ian Weitz, Dominick J Angiolillo, Tobias Geisler, et al.
Thrombosis and Haemostasis|May 7, 2020
Role of Factor XIa and Plasma Kallikrein in Arterial and Venous ThrombosisMayken Visser, Stefan Heitmeier, Hugo Ten Cate, et al.
Thrombosis Research|April 10, 2012
Similarities in thromboelastometric (ROTEM®) findings between humans and baboonsHerbert Schöchl, Cristina Solomon, Volker Laux, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2026
A novel biosensor for measuring plasmin activityYing Dai, Paul Y Kim, Stefan Heitmeier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 19, 2013
Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic strokeRobert Ploen, Li Sun, Wei Zhou, et al.
Stroke|January 24, 2013
Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxabanWei Zhou, Markus Zorn, Peter Nawroth, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology and Therapeutics|April 8, 2015
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo StudiesElisabeth Perzborn, Stefan Heitmeier, Volker Laux
Journal of Thrombosis and Thrombolysis|February 6, 2023
The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidenceSonja Schiffer, Stephan Schwers, Stefan Heitmeier
Thrombosis Research|February 18, 2014
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitroElisabeth Perzborn, Stefan Heitmeier, Volker Laux, et al.
Thrombosis Research|June 7, 2020
The dual FXa/thrombin inhibitor SATI prevents fibrin and platelet deposition in hypercoagulant ratsMercedes López, Stefan Heitmeier, Volker Laux, et al.
Thrombosis and Haemostasis|June 29, 2020
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the EvidenceJeffrey Ian Weitz, Dominick J Angiolillo, Tobias Geisler, et al.
Thrombosis and Haemostasis|May 7, 2020
Role of Factor XIa and Plasma Kallikrein in Arterial and Venous ThrombosisMayken Visser, Stefan Heitmeier, Hugo Ten Cate, et al.
Thrombosis Research|April 10, 2012
Similarities in thromboelastometric (ROTEM®) findings between humans and baboonsHerbert Schöchl, Cristina Solomon, Volker Laux, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2026
A novel biosensor for measuring plasmin activityYing Dai, Paul Y Kim, Stefan Heitmeier, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 19, 2013
Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic strokeRobert Ploen, Li Sun, Wei Zhou, et al.
Stroke|January 24, 2013
Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxabanWei Zhou, Markus Zorn, Peter Nawroth, et al.
Pageof 5